60

Hangzhou TianMuShan Pharmaceutical Enterprise Co LtdSHG 600671 Stock Report

Last reporting period 30 Sep, 2022

Updated 18 Oct, 2024

Last price

Market cap $B

0.119

Micro

Exchange

XSHG - Shanghai Stock Exchange

600671.SS Stock Analysis

60

Uncovered

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-59/100

Low score

Market cap $B

0.119

Dividend yield

Shares outstanding

121.78 B

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. engages in the sale of medicines and health products. The company is headquartered in Hangzhou, Zhejiang and currently employs 438 full-time employees. The firm is mainly engaged in the manufacture of chemical drug substances, processing of Chinese herbal pieces as well as the manufacture of traditional Chinese medicine preparation and Western medicine. The firm's main products are bright eye drops, FufangXianzhuliYe, amoxicillin and clavulanate potassium tablets, Hechedazao Jiaonang, Liu Wei Di Huang oral liquid, menthol, and peppermint oil. The firm mainly operates its business in the domestic market.

View Section: Eyestock Rating